| Dr Joshua Kagan, MD | |
|
601 John St, Kalamazoo, MI 49007-5341 | |
| (269) 341-7654 | |
| Not Available |
| Full Name | Dr Joshua Kagan |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 11 Years |
| Location | 601 John St, Kalamazoo, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457795395 | NPI | - | NPPES |
| 1457795395 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 4301501308 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bronson Methodist Hospital | Kalamazoo, MI | Hospital |
| Bronson Battle Creek Hospital | Battle creek, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Patholgy Services Of Kalamazoo Pc | 0143123034 | 15 |
| Southwest Michigan Pathology Services, Pc | 5496009433 | 11 |
News Archive
State insurance regulators won't vote any time soon on whether to endorse a bill that would exempt insurance agents from part of health care reform. A task force of the National Association of Insurance Commissioners recently recommended endorsing the bill, sponsored by Rep. Mike Rogers, that would carve out agents' and brokers' commissions from a section of the new law that limits how much insurance companies can spend on administrative costs.
Cell Therapeutics, Inc. announced the publication of results posted in the online journal of Cancer of a Phase I-II study that evaluated the safety and efficacy of pixantrone when used in combination with fludarabine, dexamethasone and rituximab replacing mitoxantrone in the standard FND-R regimen with FPD-R among 28 patients with relapsed or refractory indolent non-Hodgkin's lymphoma.
Inter Press Service has published a two-part series, made possible with support from the Fund for Investigative Journalism in Haiti, examining sanitation services in Haiti since the earthquake in 2010.
According to news reports, critics have pinpointed this part of the health law in their effort to undo the sweeping overhaul. Meanwhile, USA Today reports that very few middle-income taxpayers will pay more as a result of the measure's taxes, fees and penalties.
› Verified 2 days ago
| Entity Name | Patholgy Services Of Kalamazoo Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548243595 PECOS PAC ID: 0143123034 Enrollment ID: O20040128001118 |
News Archive
State insurance regulators won't vote any time soon on whether to endorse a bill that would exempt insurance agents from part of health care reform. A task force of the National Association of Insurance Commissioners recently recommended endorsing the bill, sponsored by Rep. Mike Rogers, that would carve out agents' and brokers' commissions from a section of the new law that limits how much insurance companies can spend on administrative costs.
Cell Therapeutics, Inc. announced the publication of results posted in the online journal of Cancer of a Phase I-II study that evaluated the safety and efficacy of pixantrone when used in combination with fludarabine, dexamethasone and rituximab replacing mitoxantrone in the standard FND-R regimen with FPD-R among 28 patients with relapsed or refractory indolent non-Hodgkin's lymphoma.
Inter Press Service has published a two-part series, made possible with support from the Fund for Investigative Journalism in Haiti, examining sanitation services in Haiti since the earthquake in 2010.
According to news reports, critics have pinpointed this part of the health law in their effort to undo the sweeping overhaul. Meanwhile, USA Today reports that very few middle-income taxpayers will pay more as a result of the measure's taxes, fees and penalties.
› Verified 2 days ago
| Entity Name | Southwest Michigan Pathology Services, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467944181 PECOS PAC ID: 5496009433 Enrollment ID: O20181112000155 |
News Archive
State insurance regulators won't vote any time soon on whether to endorse a bill that would exempt insurance agents from part of health care reform. A task force of the National Association of Insurance Commissioners recently recommended endorsing the bill, sponsored by Rep. Mike Rogers, that would carve out agents' and brokers' commissions from a section of the new law that limits how much insurance companies can spend on administrative costs.
Cell Therapeutics, Inc. announced the publication of results posted in the online journal of Cancer of a Phase I-II study that evaluated the safety and efficacy of pixantrone when used in combination with fludarabine, dexamethasone and rituximab replacing mitoxantrone in the standard FND-R regimen with FPD-R among 28 patients with relapsed or refractory indolent non-Hodgkin's lymphoma.
Inter Press Service has published a two-part series, made possible with support from the Fund for Investigative Journalism in Haiti, examining sanitation services in Haiti since the earthquake in 2010.
According to news reports, critics have pinpointed this part of the health law in their effort to undo the sweeping overhaul. Meanwhile, USA Today reports that very few middle-income taxpayers will pay more as a result of the measure's taxes, fees and penalties.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joshua Kagan, MD 5700 Southwyck Blvd, Toledo, OH 43614-1509 Ph: () - | Dr Joshua Kagan, MD 601 John St, Kalamazoo, MI 49007-5341 Ph: (269) 341-7654 |
News Archive
State insurance regulators won't vote any time soon on whether to endorse a bill that would exempt insurance agents from part of health care reform. A task force of the National Association of Insurance Commissioners recently recommended endorsing the bill, sponsored by Rep. Mike Rogers, that would carve out agents' and brokers' commissions from a section of the new law that limits how much insurance companies can spend on administrative costs.
Cell Therapeutics, Inc. announced the publication of results posted in the online journal of Cancer of a Phase I-II study that evaluated the safety and efficacy of pixantrone when used in combination with fludarabine, dexamethasone and rituximab replacing mitoxantrone in the standard FND-R regimen with FPD-R among 28 patients with relapsed or refractory indolent non-Hodgkin's lymphoma.
Inter Press Service has published a two-part series, made possible with support from the Fund for Investigative Journalism in Haiti, examining sanitation services in Haiti since the earthquake in 2010.
According to news reports, critics have pinpointed this part of the health law in their effort to undo the sweeping overhaul. Meanwhile, USA Today reports that very few middle-income taxpayers will pay more as a result of the measure's taxes, fees and penalties.
› Verified 2 days ago
Dr. Albert D Mason, MD Pathology Medicare: Medicare Enrolled Practice Location: 601 John St, Kalamazoo, MI 49007 Phone: 269-341-7654 | |
Dr. Kevin M. Herzog, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 601 John St, Kalamazoo, MI 49007 Phone: 269-341-7654 | |
Dr. Nigel H. Bramwell, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 601 John St, Kalamazoo, MI 49007 Phone: 269-341-7654 | |
Dr. William T Leeburg, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 601 John St, Kalamazoo, MI 49007 Phone: 269-341-7654 | |
William J Walter, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 1521 Gull Rd, Kalamazoo, MI 49048 Phone: 269-226-7000 | |
Dr. William P Walker, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 601 John St, Kalamazoo, MI 49007 Phone: 269-341-7654 | |
Steven P Soper, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 1521 Gull Rd, Kalamazoo, MI 49048 Phone: 269-226-7000 |